The prognostic ability of MCT4 or the DNA methylation in the SLC16A3 promoter has been identified in ccRCC previously, but data for the prognostic potential of CD147 and its epigenetic regulation are limited [11, 13]. The gene discussed is SLC16A3; the disease is nonpapillary renal cell carcinoma.